← Every applicant
Corepharma FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DEXAMETHASONENew drugSep 17, 2024TABLET, ORAL |
| CHLORZOXAZONENew drugApr 10, 2023TABLET, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugMar 24, 2023CAPSULE, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugNov 28, 2022TABLET, ORAL |
| CHLORZOXAZONENew drugOct 20, 2022TABLET, ORAL |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDENew drugJul 29, 2022CAPSULE, ORAL |
| CLORAZEPATE DIPOTASSIUMNew drugJun 14, 2022TABLET, ORAL |
| PIOGLITAZONE HYDROCHLORIDENew drugJan 22, 2021TABLET, ORAL |